Reducing Costs by Deprescribing Medications

NACompletedINTERVENTIONAL
Enrollment

419

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

June 1, 2022

Study Completion Date

June 1, 2022

Conditions
PolypharmacyDeprescribingAdverse Drug Reaction
Interventions
BEHAVIORAL

Deprescribing Intervention

An individualized deprescribing intervention will be created by a pharmacist working with a patient to identify harmful, costly, and unnecessary medications to be reduced. The intervention will include a plan and monitoring for up to 3 months to reduce medication use.

BEHAVIORAL

Usual Care

The usual care arm will receive the current standard of care, which includes medication reconciliation by a clinic nurse at the time of their appointment. Nurses review all medications and answer medication-related questions, and refer medication questions to the healthcare provider for further discussion when necessary.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

Blue Cross Blue Shield

OTHER

lead

The University of Texas Health Science Center, Houston

OTHER

NCT04553107 - Reducing Costs by Deprescribing Medications | Biotech Hunter | Biotech Hunter